Researchers tracked 935 individuals between 2019 and 2022, utilizing Oura Ring data to monitor sleep duration outside of clinical laboratory settings. The findings indicate a dose-dependent relationship: participants who used the device for at least three hours overnight experienced a 77% reduction in the likelihood of sleeping fewer than six hours. The technology, which delivers low-frequency vibrations to the skin, aims to stimulate the vagus nerve to promote physiological recovery and calm.

Dr. David M. L. Rabin, Chief Medical Officer at Apollo Neuroscience, noted that the results compare favorably to leading prescription sleep medications without the associated risks of dependency or next-day impairment. The study observed that consistent use not only increased total sleep time but also helped preserve deep sleep cycles. According to CEO Kathryn Fantauzzi, the data is particularly compelling because it reflects real-world usage rather than controlled environments, proving that significant health improvements can occur without intensive behavioral coaching. Since the study concluded, the company has integrated these insights into its SmartVibes AI, which automatically adjusts stimulation based on real-time biometric feedback.